The Need for Biochemical Testing for Alcohol in Integrated Addiction Treatment Settings During the Opioid Epidemic.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33273253.
- Also identified by DOI 10.1097/ADM.0000000000000784.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As the opioid crisis drives expansion of integrated opioid use disorder (OUD) treatment programs in generalist settings, these programs will contend with significant rates of co-occurring alcohol use. The authors present a brief literature review and commentary regarding nondisordered and disordered alcohol use in OUD treatment settings and biochemical detection techniques. Biochemical testing for alcohol in integrated OUD treatment settings is both important for detecting alcohol use disorder and feasible. Breathalyzer testing may assist with management of acutely intoxicated patients. Biochemical testing for alcohol is an important part of integrated OUD treatment. More research is needed on the impact of alcohol use on OUD treatment outcomes and the role of breathalyzer testing in management of intoxicated patients in the outpatient setting.
Medical subject headings
- Alcoholism
- Behavior, Addictive
- Opioid-Related Disorders